NCT01488201 A Clinical Pharmacology of KHK4827 in Healthy Volunteers and Subject With Moderate to Severe Psoriasis Status COMPLETED Phase PHASE1
NCT01484587 A Study of the Safety, Tolerability, Pharmacokinetics (What the Body Does to the Drug), and Pharmacodynamics (What the Drug Does to the Body) of CNTO 1959 Following a Single Subcutaneous (Under the Skin) Administration in Japanese Participants With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE1
NCT01483599 A Study to Evaluate CNTO 1959 in the Treatment of Patients With Moderate to Severe Plaque-type Psoriasis Status COMPLETED Phase PHASE2
NCT01474512 A Phase 3 Study in Participants With Moderate to Severe Psoriasis Status COMPLETED Phase PHASE3
NCT01465061 A Survey on the Role and Benefits of Online Social Networks on Filipino Patients With Psoriasis Status COMPLETED Phase N/A
NCT01462643 Efficacy and Tolerability of LAS41004 Formulations in a Non-occlusive Psoriasis Plaque Test Status COMPLETED Phase PHASE2
NCT01439425 Weight Reduction Alone May Not be Sufficient to Maintain Disease Remission in Obese Patients With Psoriasis Status UNKNOWN Phase PHASE4
NCT01435265 Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab Status COMPLETED Phase NA
NCT01429870 Steroids Added to Dithranol and Narrow Band UVB(Ultraviolet B) (UVBnb) in Psoriasis Status WITHDRAWN Phase PHASE4
NCT01404338 Assessment for Tachyphylaxis to Topical Corticosteroids in the Treatment of Psoriasis Status COMPLETED Phase PHASE1
NCT01403012 BOSTRIP: Biomarkers of Systemic Treatment Response in Psoriasis Status TERMINATED Phase N/A
NCT01387815 Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis Status COMPLETED Phase N/A
NCT01384630 Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis Status COMPLETED Phase PHASE2
NCT01382784 Psoriasis and the Risk of Cardiovascular Disease. A Prospective Study Status UNKNOWN Phase N/A
NCT01368887 Study to Test the Effectiveness of a New Treatment for Scalp Psoriasis Status SUSPENDED Phase PHASE2
NCT01360944 Exploratory Study to Investigate Efficacy of LAS41004 in a Psoriasis Plaque Test Status COMPLETED Phase PHASE2